Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Altamura

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
The Journal of Headache and Pain|December 19, 2021
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort studyFabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Cerebrovascular Diseases Extra|January 27, 2017
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery StentingPaola Maggio, Claudia Altamura, Domenico Lupoi, et al.
Sleep Medicine|March 22, 2024
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter studyGiovanna Viticchi, Vincenzo Di Stefano, Claudia Altamura, et al.
Neurology|September 14, 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery diseaseMatthias Reinhard, Guido Schwarzer, Matthias Briel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 27, 2020
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, et al.
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
European Journal of Neurology|September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT studyFabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Biomedicines|February 24, 2024
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort StudyAnnalisa Marino, Damiano Currado, Claudia Altamura, et al.
Journal of the Neurological Sciences|March 21, 2013
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairmentPaola Maggio, Claudia Altamura, Doriana Landi, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
The Journal of Headache and Pain|December 19, 2021
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort studyFabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Cerebrovascular Diseases Extra|January 27, 2017
The Role of White Matter Damage in the Risk of Periprocedural Diffusion-Weighted Lesions after Carotid Artery StentingPaola Maggio, Claudia Altamura, Domenico Lupoi, et al.
Sleep Medicine|March 22, 2024
Effects of prophylactic drug therapies and anti-calcitonin peptide-related monoclonal antibodies on subjective sleep quality: An Italian multicenter studyGiovanna Viticchi, Vincenzo Di Stefano, Claudia Altamura, et al.
Neurology|September 14, 2014
Cerebrovascular reactivity predicts stroke in high-grade carotid artery diseaseMatthias Reinhard, Guido Schwarzer, Matthias Briel, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 27, 2020
Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study)Fabrizio Vernieri, Claudia Altamura, Cinzia Aurilia, et al.
Frontiers in Neurology|April 16, 2026
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study)Luisa Fofi, Claudia Altamura, Marilena Marcosano, et al.
European Journal of Neurology|September 13, 2022
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT studyFabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, et al.
Biomedicines|February 24, 2024
Increased Prevalence of Headaches and Migraine in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: Insights from an Italian Cohort StudyAnnalisa Marino, Damiano Currado, Claudia Altamura, et al.
Journal of the Neurological Sciences|March 21, 2013
Diffusion-weighted lesions after carotid artery stenting are associated with cognitive impairmentPaola Maggio, Claudia Altamura, Doriana Landi, et al.
Journal of Neurology|July 19, 2023
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO studyFabrizio Vernieri, Nicoletta Brunelli, Simona Guerzoni, et al.
Pageof 14